International Biotechnology Trust plc (IBT) is an investment trust company listed on the London Stock Exchange which invests in companies within biotechnology sector.
London, WC2B 6ST
England, United Kingdom
|2015-07-10||Autifony Therapeutics||Series A - II||$12.4M||Pfizer Venture Investments, SV Health Investors, Touchstone Innovations, and UCL Business|
|2012-09-06||Karus Therapeutics||Series B||$7.6M||IP Group, New Leaf Venture Partners, Novo Ventures, SV Health Investors, and Undisclosed Angel Investors|
|2010-09-09||Sunesis Pharmaceuticals||PIPE - III||$15.5M||Abingworth, Alta Partners, Bay City Capital, BVF Partners, Deerfield Management, Domain Associates, International Biomedicine Management Partners, LODH Private Equity Partners, Mayfield Fund, Merlin Nexus, New Enterprise Associates, Nextech Venture, NMT Management AG - New Medical Technologies, OpusPoint Partners, Skyline Ventures, SV Health Investors, Venrock, Vision Capital Advisors, and Warburg Pincus|
|2009-10-21||Lux Biosciences||Series B||$50M||HBM Healthcare Investments, Novo Holdings, Prospect Venture Partners, and SV Health Investors|
|2007-10-18||Sutro Biopharma||Unattributed VC||$0.3M||SV Health Investors|